25/05/2005 - The boundary between the pharma and biotech industries will become incresingly blurred over the next 10 years, with the latter enjoying stronger growth, writes Phil Taylor.
link from in-pharma-tech.com
Wednesday, May 25, 2005
Biotech to outpace pharma, says Deloitte
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment